172 related articles for article (PubMed ID: 9584851)
1. Tumor-specific pyruvate kinase isoenzyme M2 involved in biochemical strategy of energy generation in neoplastic cells.
Gumińska M; Ignacak J; Kedryna T; Stachurska MB
Acta Biochim Pol; 1997; 44(4):711-24. PubMed ID: 9584851
[TBL] [Abstract][Full Text] [Related]
2. Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells.
Mazurek S
Int J Biochem Cell Biol; 2011 Jul; 43(7):969-80. PubMed ID: 20156581
[TBL] [Abstract][Full Text] [Related]
3. Pyruvate kinase isoenzyme M2 is a glycolytic sensor differentially regulating cell proliferation, cell size and apoptotic cell death dependent on glucose supply.
Spoden GA; Rostek U; Lechner S; Mitterberger M; Mazurek S; Zwerschke W
Exp Cell Res; 2009 Oct; 315(16):2765-74. PubMed ID: 19563799
[TBL] [Abstract][Full Text] [Related]
4. Double role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells.
Eigenbrodt E; Reinacher M; Scheefers-Borchel U; Scheefers H; Friis R
Crit Rev Oncog; 1992; 3(1-2):91-115. PubMed ID: 1532331
[TBL] [Abstract][Full Text] [Related]
5. N-acetylneuraminic acid, phosphate and thiol groups of pyruvate kinase isoenzymes from Morris hepatoma 7777 and normal rat liver.
Ignacak J; Gumińska M
Acta Biochim Pol; 1997; 44(2):201-8. PubMed ID: 9360708
[TBL] [Abstract][Full Text] [Related]
6. Structural and kinetic differences between the M2 type pyruvate kinases from lung and various tumors.
Eigenbrodt E; Leib S; Krămer W; Friis RR; Schoner W
Biomed Biochim Acta; 1983; 42(11-12):S278-82. PubMed ID: 6326772
[TBL] [Abstract][Full Text] [Related]
7. The tumor metabolome.
Mazurek S; Eigenbrodt E
Anticancer Res; 2003; 23(2A):1149-54. PubMed ID: 12820363
[TBL] [Abstract][Full Text] [Related]
8. Glucose metabolism and angiogenesis in granulosa cell tumors of the ovary: activation of Akt, expression of M2PK, TKTL1 and VEGF.
Schmidt M; Kammerer U; Segerer S; Cramer A; Kohrenhagen N; Dietl J; Voelker HU
Eur J Obstet Gynecol Reprod Biol; 2008 Jul; 139(1):72-8. PubMed ID: 18394773
[TBL] [Abstract][Full Text] [Related]
9. Adenylate kinase I does not affect cellular growth characteristics under normal and metabolic stress conditions.
de Bruin W; Oerlemans F; Wieringa B
Exp Cell Res; 2004 Jul; 297(1):97-107. PubMed ID: 15194428
[TBL] [Abstract][Full Text] [Related]
10. Metabolic cooperation between different oncogenes during cell transformation: interaction between activated ras and HPV-16 E7.
Mazurek S; Zwerschke W; Jansen-Dürr P; Eigenbrodt E
Oncogene; 2001 Oct; 20(47):6891-8. PubMed ID: 11687968
[TBL] [Abstract][Full Text] [Related]
11. In vitro inhibitory effect of chitosan and its degradation products on energy metabolism in Ehrlich ascites tumour cells (EAT).
Gumińska M; Ignacak J; Wójcik E
Pol J Pharmacol; 1996; 48(5):495-501. PubMed ID: 9112691
[TBL] [Abstract][Full Text] [Related]
12. Marker for renal cell carcinoma (RCC): the dimeric form of pyruvate kinase type M2 (Tu M2-PK).
Wechsel HW; Petri E; Bichler KH; Feil G
Anticancer Res; 1999; 19(4A):2583-90. PubMed ID: 10470199
[TBL] [Abstract][Full Text] [Related]
13. Electrophoretic pattern of cytosolic pyruvate kinase fractions A and B (type L and M2) from normal rat liver and Morris hepatoma 7777.
Gumińska M; Ignacak J
Biochim Biophys Acta; 1996 Jan; 1292(1):99-105. PubMed ID: 8547355
[TBL] [Abstract][Full Text] [Related]
14. Amino-acid composition of pyruvate kinase M2 isoenzyme variants from rat liver and Morris hepatoma 7777.
Ignacak J; Gumińska M; Steczko J
Acta Biochim Pol; 1998; 45(3):775-80. PubMed ID: 9918504
[TBL] [Abstract][Full Text] [Related]
15. Pyruvate kinase type M2: a crossroad in the tumor metabolome.
Mazurek S; Grimm H; Boschek CB; Vaupel P; Eigenbrodt E
Br J Nutr; 2002 Jan; 87 Suppl 1():S23-9. PubMed ID: 11895152
[TBL] [Abstract][Full Text] [Related]
16. Comparison of pyruvate kinase variants from rat liver and Morris hepatoma 7777, obtained by an affinity chromatography on blue sepharose CL-6B.
Ignacak J; Gumińska M
Acta Biochim Pol; 1993; 40(2):261-7. PubMed ID: 8212964
[TBL] [Abstract][Full Text] [Related]
17. Pyruvate kinase M2 and cancer: an updated assessment.
Iqbal MA; Gupta V; Gopinath P; Mazurek S; Bamezai RN
FEBS Lett; 2014 Aug; 588(16):2685-92. PubMed ID: 24747424
[TBL] [Abstract][Full Text] [Related]
18. Cancer metabolism: When more is less.
Jiang L; Deberardinis RJ
Nature; 2012 Sep; 489(7417):511-2. PubMed ID: 23018962
[No Abstract] [Full Text] [Related]
19. Pyruvate kinase isoenzyme M2 is not of diagnostic relevance as a marker for oral cancer.
Ervens J; Fuchs H; Niemann VT; Hoffmeister B
J Craniomaxillofac Surg; 2008 Mar; 36(2):89-94. PubMed ID: 18243718
[TBL] [Abstract][Full Text] [Related]
20. Tumor M2-PK and glutaminolytic enzymes in the metabolic shift of tumor cells.
Mazurek S; Grimm H; Oehmke M; Weisse G; Teigelkamp S; Eigenbrodt E
Anticancer Res; 2000; 20(6D):5151-4. PubMed ID: 11326687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
